Fatty acid [g/day] | Treatment1 | SEM | P-value | ||
---|---|---|---|---|---|
 | CON | CLA |  | Trt | Trt x WL2 |
4:0 | 37.5 | 37.0 | 2.6 | 0.906 | 0.528 |
6:0 | 27.2 | 22.9 | 1.5 | 0.051 | 0.496 |
8:0 | 15.4 | 12.1* | 0.74 | 0.005 | 0.809 |
10:0 | 36.9 | 26.8* | 1.6 | 0.000 | 0.987 |
12:0 | 39.3 | 27.8* | 1.7 | 0.000 | 0.926 |
14:0 | 11.5 | 92.4* | 4.2 | 0.005 | 0.992 |
c 9-14:1 | 6.3 | 4.5* | 0.36 | 0.002 | 0.561 |
15:0 | 12.0 | 10.1* | 0.59 | 0.035 | 0.991 |
16:0 | 301 | 237* | 11.8 | 0.001 | 0.199 |
c 9-16:1 | 12.2 | 12.3 | 0.84 | 0.924 | 0.436 |
17:0 | 6.1 | 6.0 | 0.35 | 0.728 | 0.658 |
18:0 | 97.8 | 92.1 | 8.4 | 0.633 | 0.402 |
t 6/t 7/t 8-18:1 | 1.6 | 2.1 | 0.17 | 0.063 | 0.663 |
t 9-18:1 | 2.0 | 2.3 | 0.12 | 0.088 | 0.414 |
t 10-18:1 | 4.2 | 6.8 | 1.1 | 0.096 | 0.822 |
t 11-18:1 | 7.3 | 8.7 | 0.77 | 0.215 | 0.240 |
t 12-18:1 | 2.1 | 2.6* | 0.15 | 0.030 | 0.352 |
t 13/t 14-18:1 | 2.3 | 2.6 | 0.16 | 0.227 | 0.993 |
c 9-18:1 | 172 | 183 | 16.0 | 0.633 | 0.336 |
c 11-18:1 | 8.1 | 8.5 | 0.63 | 0.602 | 0.649 |
c 12-18:1 | 1.7 | 2.1* | 0.14 | 0.032 | 0.605 |
c 13-18:1 | 0.91 | 1.0 | 0.08 | 0.662 | 0.249 |
18:2 n-6 | 14 | 14.8 | 0.95 | 0.571 | 0.016 |
18:3 n-3 | 0.23 | 0.2 | 0.01 | 0.104 | 0.857 |
CLA | |||||
  c 9,t 11-CLA | 3.5 | 4.4* | 0.30 | 0.039 | 0.787 |
  t 10,c 12-CLA | 0.01 | 0.42* | 0.02 | 0.000 | 0.125 |
  Other CLA | 0.74 | 0.97* | 0.07 | 0.022 | 0.787 |
Summations | |||||
  ∑ SFA | 708 | 585* | 29.5 | 0.008 | 0.617 |
  ∑ MUFA | 230 | 246 | 18.9 | 0.563 | 0.394 |
  ∑ PUFA | 25.3 | 27.8 | 1.8 | 0.335 | 0.143 |
  ∑ trans-18:1 | 24.3 | 30.7 | 2.18 | 0.054 | 0.998 |
  ∑ BCFA3 | 16.4 | 15.7 | 0.74 | 0.520 | 0.567 |
  ∑ C164 | 314 | 249* | 12.4 | 0.002 | 0.191 |
  ∑ de novo5 | 300 | 246* | 11.7 | 0.003 | 0.950 |
  ∑ preformed6 | 350 | 365 | 28.2 | 0.716 | 0.262 |
Ratio | |||||
  c 9-14:1/14:0 | 0.54 | 0.41* | 0.03 | 0.006 | 0.434 |